Article Information
History
- May 7, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Brendan Day, MD, MPH1,*,
- David Menschik, MD, MPH1,
- Deborah Thompson, MD, MPH1,
- Christopher Jankosky, MD, MPH1,
- John Su, MD, PhD, MPH2,
- Pedro Moro, MD, MPH2,
- Craig Zinderman, MD, MPH1,
- Kerry Welsh, MD, PhD1 and
- Narayan Nair, MD1
- 1Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland
- 2Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
- ↵*Corresponding author:
Brendan Day, MD, MPH, Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, Maryland 20903 (brendan.day{at}fda.hhs.gov).
Posted May 07, 2022.
Reporting Rates for VAERS Death Reports Following COVID-19 Vaccination, December 14, 2020-November 17, 2021
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
13
Blogs/Media
Author Videos